FindTrial
Sign In

Neonatal urine proteomics analysis and related disease marker studies

Neonatal urine proteomics analysis and related disease marker studies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101643
Enrollment
Unknown
Registered
2025-04-28
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature

Interventions

Experimental group:None
Full-term control group:None
Preterm birth control group:None

Sponsors

7th Medical Center of chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Experimental group: (1) admitted to the neonatal intensive care unit within 24 hours of birth and born with a gestational age of = 37 weeks old; (2) Informed consent of the guardian to participate in this study; 3.Preterm birth control group: (1) healthy preterm infants born within 24 hours of birth and born at gestational age < 37 weeks; (2) Informed consent of the guardian to participate in this study;

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Proteomic differences;—

Countries

China

Contacts

Public ContactQiuping Li

7th Medical Center of chinese PLA General Hospital

sdkongxy@126.com+86 10 8400 8807

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026